Notice of NIDCD Participation in PAR-21-251 "Emerging Global Leader Award (K43 Independent Clinical Trial Required)" and PAR-21-252 “Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)”
Notice Number:
NOT-DC-23-007

Key Dates

Release Date:

April 6, 2023

Related Announcements

PAR-21-251 - Emerging Global Leader Award (K43 Independent Clinical Trial Required)

PAR-21-252 - Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

Issued by

National Institute on Deafness and Other Communication Disorders (NIDCD)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute on Deafness and Other Communication Disorders (NIDCD) is participating, effective immediately, in PAR-21-251 "Emerging Global Leader Award (K43 Independent Clinical Trial Required)" and PAR-21-252 “Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)”.

The following text has been updated to reflect the participation of NIDCD in this Notice of Funding Opportunity (NOFO).

Part 1. Overview Information

Components of Participating Organizations

National Institute on Deafness and Other Communication Disorders (NIDCD)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.173

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Interests of Participating NIH Institutes, Centers and Offices

The mission of the National Institute on Deafness and Other Communication Disorders (NIDCD) is to improve the lives of the millions of people with hearing loss and other communication disorders, spanning functions of hearing, balance, taste, smell, voice, speech, and language. For the purpose of this initiative, NIDCD is especially interested in applications focused on the following topics within the NIDCD mission: otitis media, hearing loss, early hearing detection and intervention including newborn screening programs, chemosensory loss, health services, habilitation and rehabilitation services, dissemination and implementation research, and cultural and linguistic adaptations of diagnostic and intervention tools for communication disorders.  Applications from institutions within a geographic region that share the same spoken language (e.g., Spanish in Latin America, Arabic in the Middle East and North Africa, etc.) could offer special opportunities for regional collaboration. Prospective applicants are encouraged to review the current NIDCD Strategic Plan on the NIDCD website.

Section VII. Agency Contacts

Scientific/Research Contact

Alberto L. Rivera-Rentas, Ph.D.
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-496-1804
Email: riverara@nidcd.nih.gov

Financial/Grants Management Contact

Christopher Myers
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-402-0909
Email: myersc@mail.nih.gov

Inquiries

Please direct all inquiries to:

Alberto L. Rivera-Rentas, Ph.D.
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-496-1804
Email: riverara@nidcd.nih.gov